DRL forays into health drink segment
Dr Reddy’s Laboratories Ltd has forayed into the nutrition segment with the launch of ‘Celevida’ in India. The first-of-its-kind health drink has been proven to […]
DRL
DRL receives USFDA approval for Tosymra – migraine spray
Dr Reddy’s Laboratories Ltd has received USFDA approval for ‘Tosymra’ spray which is used to treat acute migraine with or without aura in adults. The […]
DRL launches Chlorthalidone tablets in US Markets
Dr Reddy’s Laboratories has launched Chlorthalidone tablets which is used to treat high blood pressure, in the US market. The drug will be made available […]
DRL makes deal to sell its API unit in Hyderabad
Dr Reddy’s Labs (DRL) has entered into a definitive agreement for the sale of Active Pharma Ingredients (API) manufacturing business unit located in Jeedimetla, Hyderabad, […]
DRL receives USFDA approval for extended-release Dipyridamole capsules
Dr Reddy’s Laboratories Ltd has received USFDA approval for Aspirin and extended-release Dipyridamole capsules. The drug is a therapeutic equivalent generic version of Aggrenox (Aspirin […]
DRL launches Clofarbine injection in US Markets
Dr. Reddy s Laboratories Ltd has launched Clofarabine Injection, a therapeutic equivalent generic version of Clolar (clofarabine) Injection in the United States market. The company […]
DRL launches nystatin and triamcinolone acetonide cream in USA
Dr Reddy’s Laboratories Ltd has launched nystatin and triamcinolone acetonide cream USP, in the United States market which has been approved by the USFDA. The […]
DRL launches Nitrostat tablets in US
Dr Reddy’s Laboratories has launched Nitroglycerin sublingual tablets, a therapeutic equivalent generic version of Nitrostat (Nitroglycerin) sublingual tablets in the US. The drug which is […]
DRL signs agreeement with CutisPharma
Dr. Reddys Laboratories has signed up Cutis Pharma of USA for active pharmaceutical ingredient (API) supply and joint development agreements. The company will engage in […]
Dr. Reddys Lab receives USFDA approval for Sernivo spray
Dr. Reddys Laboratories through its subsidiary Promius Pharma has received USFDA approval to market Sernivo spray, used in treatment of skin disorder. The drug Sernivo […]